Tag: equity
-
Device Spin-Off Raises $2.2M in Seed Funds
A medical technology company developing a sensor device that monitors catheters draining excess brain fluid is raising $2.2 million in seed funds.
-
Life Science Investors Add New $650M Fund
A venture capital investor specializing in health care and life science companies raised $650 million for new financing rounds.
-
Messenger RNA Developer ETF Launches
A new exchange traded fund or ETF is underway for individuals to invest in companies developing vaccines or therapies with messenger RNA.
-
AI-Aided Fall Prevention System Gains $30M in New Funds
A developer of a system using artificial intelligence to process video for preventing falls by older people is raising $30 million in its second venture round.
-
$180M Venture Fund Backing Age-Related Disease Start-Ups
A new venture capital fund aims to finance research entrepreneurs addressing root causes of age-related diseases with therapies and early diagnostics.
-
Plant-Based Protein Biotech Raises $3M in Seed Funds
A biotechnology start-up producing proteins with more sustainable and less costly plant-based processes is raising $3 million in its seed funding round.
-
Regeneron Gains Cancer, Infectious Disease Immunotherapies
A biotechnology company is licensing five of its vaccines for cancer and infectious diseases to Regeneron Pharmaceuticals in a deal valued at nearly $1 billion.
-
Infographic – U.S. Venture Funding States Left Behind
Crunchbase News reported on parts of the U.S. getting the fewest venture dollars, displayed in today’s infographic.
-
Cell Therapy Start-Up Raises $6M in Seed Funds
A new company providing clinical development and commercialization for emerging cell therapies began operations and raised $6 million in seed funding.
-
Novo Nordisk Buys RNA Biotech in $3.3B Deal
Global drug maker Novo Nordisk is acquiring biotechnology company Dicerna Pharmaceuticals Inc. in an all-cash deal valued at $3.3 billion.